Abstract 44 Table 1 Discharge medications for patients with LVSD and EF <35% (Total patients 156)
| Drug Class | Patient No | % on Evidence based Max dose | Most commonly used drug (%) | |
|---|---|---|---|---|
| Angiotensin-converting enzyme Inhibitor (figure 1) | 106 | 71% | Ramipril | 94% |
| Angiotensin receptor blocker | 20 | 29% | Candesartan | 85% |
| Angiotensin Receptor Neprilysin Inhibitor | 10 | 63% | Entresto | 100% |
| Beta-Blocker (figure 2) | 135 | 50% | Bisoprolol | 95% |
| Mineralocorticoid/aldosterone receptor antagonist | 69 | 75% | Spironolactone | 74% |